Basic Information
| LncRNA/CircRNA Name | PIK3CD-AS2 |
| Synonyms | NA |
| Region | GRCh38_1:9672426-9687555 |
| Ensemble | ENSG00000231789 |
| Refseq | NR_126366 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qRT-PCR, Western blot |
| Sample | LUAD tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | PIK3CD-AS2 regulates LUAD progression and elucidate a new PIK3CD-AS2/YBX1/p53 signaling axis. |
| Pubmed ID | 32165621 |
| Year | 2020 |
| Title | The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway |
External Links
| Links for PIK3CD-AS2 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |